ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Medical Oncology

Top Medical Oncology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RAND ALTEMOSE M.D.

Medical Oncology

4,106

$817K

1383
953 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 20%

$199
Average prescription price

Avg: $515

NOOR MERCHANT M.D.

Medical Oncology

1,832

$1.54M

278
244 are 65+

20%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 20%

$839
Average prescription price

Avg: $515

VIRALKUMAR BHANDERI M.D.

Medical Oncology

1,798

$955K

259
213 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 20%

$531
Average prescription price

Avg: $515

ABRAHAM SCHWARZBERG MD

Medical Oncology

1,758

$1.66M

235
218 are 65+

22%
patients receiving schedule two controlled substances

Avg: 14%

12%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 20%

$946
Average prescription price

Avg: $515

SHALIN SHAH D.O.

Medical Oncology

1,731

$822K

304
238 are 65+

10%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 20%

$475
Average prescription price

Avg: $515

FRED SCHREIBER MD

Medical Oncology

1,667

$516K

198
173 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 20%

$310
Average prescription price

Avg: $515

ROBERT WHORF M.D.

Medical Oncology

1,585

$800K

277
242 are 65+

17%
patients receiving schedule two controlled substances

Avg: 14%

10%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 20%

$505
Average prescription price

Avg: $515

RAJU RAO MD

Medical Oncology

1,506

$425K

259
188 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 20%

$282
Average prescription price

Avg: $515

DOUGLAS HELDRETH M.D.

Medical Oncology

1,503

$658K

238
226 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

10%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 20%

$438
Average prescription price

Avg: $515

MARK MOSKOWITZ MD

Medical Oncology

1,480

$1.01M

267
241 are 65+

16%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 20%

$680
Average prescription price

Avg: $515

LUIS FRANCO MD

Medical Oncology

1,328

$391K

237
210 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 20%

$294
Average prescription price

Avg: $515

SYED AHMED M.D.

Medical Oncology

1,122

$968K

258
221 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 20%

$862
Average prescription price

Avg: $515

GAIL WRIGHT M.D.

Medical Oncology

1,102

$463K

175
127 are 65+

17%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 20%

$420
Average prescription price

Avg: $515

MARIA MALLARINO M.D.

Medical Oncology

1,099

$532K

202
182 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

15%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 20%

$484
Average prescription price

Avg: $515

BRIAN BERRY M.D., PHD

Medical Oncology

1,096

$739K

189
168 are 65+

20%
patients receiving schedule two controlled substances

Avg: 14%

10%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 20%

$674
Average prescription price

Avg: $515

SAMINA REZA MD

Medical Oncology

1,082

$898K

241
200 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 20%

$830
Average prescription price

Avg: $515

LEE SCHEINBART MD

Medical Oncology

1,007

$502K

156
142 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

10%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 20%

$499
Average prescription price

Avg: $515

MARY LI M.D.

Medical Oncology

956

$458K

223
183 are 65+

23%
patients receiving schedule two controlled substances

Avg: 14%

10%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 20%

$479
Average prescription price

Avg: $515

DAVID DRESDNER MD

Medical Oncology

945

$637K

139
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 20%

$674
Average prescription price

Avg: $515

MARILYN RAYMOND M.D.

Medical Oncology

936

$369K

148
117 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 20%

$394
Average prescription price

Avg: $515

STEVEN NEWMAN MD

Medical Oncology

923

$573K

113
100 are 65+

10%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 20%

$621
Average prescription price

Avg: $515

RAMESH SHAH M.D.

Medical Oncology

917

$326K

134
99 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 6%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 20%

$356
Average prescription price

Avg: $515

JAMES WATKINS M.D.

Medical Oncology

910

$276K

119
71 are 65+

34%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 6%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 20%

$303
Average prescription price

Avg: $515

THOMAS JOHNSON M.D.

Medical Oncology

870

$133K

112
74 are 65+

23%
patients receiving schedule two controlled substances

Avg: 14%

21%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 20%

$153
Average prescription price

Avg: $515

ALPANA DESAI M.D.

Medical Oncology

869

$533K

169
146 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 20%

$613
Average prescription price

Avg: $515

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank